| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
major histocompatibility complex, class II, DR beta 5 | 0.608 | 0.731 | 3.6E-07 |
|
disease | 0.100 | None | 0.967 | 1 | 0 | 1976 | 2019 | ||||||||
|
major histocompatibility complex, class I, A | 0.370 | 0.846 | 1.3E-03 |
|
disease | 0.200 | None | 0.919 | 1 | 0 | 1978 | 2019 | ||||||||
|
major histocompatibility complex, class I, B | 0.379 | 0.885 | 3.9E-05 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 1979 | 2019 | ||||||||
|
CD8a molecule | 0.587 | 0.769 | 1.7E-05 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 1987 | 2008 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.300 | None | 0.880 | 8 | 0 | 1990 | 2020 | ||||||||
|
myelin basic protein | 0.510 | 0.885 | 0.28 |
|
disease | 0.100 | None | 0.939 | 8 | 0 | 1990 | 2020 | ||||||||
|
interleukin 2 | 0.336 | 0.885 | 0.48 |
|
disease | 0.100 | None | 0.967 | 2 | 0 | 1990 | 2019 | ||||||||
|
major histocompatibility complex, class II, DQ beta 1 | 0.407 | 0.885 | 8.9E-03 |
|
disease | 0.400 | None | 0.912 | 6 | 0 | 1991 | 2019 | ||||||||
|
major histocompatibility complex, class II, DQ alpha 1 | 0.416 | 0.846 | 2.4E-02 |
|
disease | 0.200 | None | 0.884 | 2 | 0 | 1991 | 2019 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.500 | None | 0.923 | 19 | 0 | 1992 | 2020 | ||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
disease | 0.400 | None | 0.877 | 7 | 0 | 1994 | 2019 | ||||||||
|
interferon gamma | 0.288 | 0.962 | 0.47 |
|
disease | 0.400 | None | 0.970 | 4 | 0 | 1994 | 2020 | ||||||||
|
intercellular adhesion molecule 1 | 0.364 | 0.962 | 3.5E-02 |
|
disease | 0.400 | None | 0.846 | 3 | 0 | 1994 | 2019 | ||||||||
|
interleukin 2 receptor subunit alpha | 0.389 | 0.885 | 5.5E-02 |
|
disease | 0.500 | None | 0.985 | 3 | 0 | 1994 | 2019 | ||||||||
|
CD44 molecule (Indian blood group) | 0.363 | 0.962 | 2.4E-07 |
|
disease | 0.040 | None | 1.000 | 1 | 0 | 1994 | 2017 | ||||||||
|
myelin oligodendrocyte glycoprotein | 0.546 | 0.731 | 0.14 |
|
disease | 0.100 | None | 0.972 | 7 | 0 | 1995 | 2020 | ||||||||
|
major histocompatibility complex, class I, C | 0.415 | 0.846 | 1.6E-06 |
|
disease | 0.100 | None | 1.000 | 1 | 0 | 1995 | 2017 | ||||||||
|
NADH dehydrogenase, subunit 1 (complex I) | 0.522 | 0.769 |
|
disease | 0.030 | None | 1.000 | 1 | 0 | 1995 | 2008 | |||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
disease | 0.100 | None | 0.957 | 4 | 0 | 1996 | 2019 | ||||||||
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
disease | 0.400 | None | 0.922 | 4 | 0 | 1996 | 2019 | ||||||||
|
crystallin alpha B | 0.515 | 0.731 | 2.2E-02 |
|
disease | 0.100 | None | 1.000 | 3 | 0 | 1996 | 2019 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
disease | 0.100 | None | 0.927 | 2 | 0 | 1996 | 2019 | ||||||||
|
plasminogen activator, tissue type | 0.445 | 0.885 | 5.7E-05 |
|
disease | 0.060 | None | 1.000 | 1 | 0 | 1996 | 2018 | ||||||||
|
TIMP metallopeptidase inhibitor 1 | 0.380 | 0.885 | 0.50 |
|
disease | 0.100 | None | 1.000 | 1 | 0 | 1996 | 2018 | ||||||||
|
serpin family E member 1 | 0.359 | 0.885 | 4.4E-02 |
|
disease | 0.060 | None | 1.000 | 1 | 0 | 1996 | 2018 |